Common use of Scope of Use Clause in Contracts

Scope of Use. 2.1 Subject to the terms of this MTA, Principal Investigator may use the EVERCYTE Materials provided to Purchaser by EVERCYTE during the License Term for non-exclusive research purposes in one Principal Investigator’s laboratory only. EVERCYTE Material is not intended for use in humans. Purchaser agrees that EVERCYTE Materials designated as biosafety greater than 1 constitute known pathogens and that EVERCYTE Materials not designated this way may be pathogenic under certain conditions (for further details see PDS). Purchaser assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and Purchaser’s use of the EVERCYTE Materials including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser agrees that any activity undertaken with the EVERCYTE Materials will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaser’s receipt, handling, storage, disposal, transfer and use of the EVERCYTE Materials. 2.2 Purchaser shall not distribute, sell, lend or otherwise transfer, to a person other than the Principal Investigator, or entity not party to this MTA, the EVERCYTE Material, as defined above, for any reason, without EVERCYTE’s prior written consent. Purchaser may not transfer the EVERCYTE Material to any third parties. Purchaser agrees that any investigator other than the Principal Investigator utilizing the EVERCYTE Material will be required to obtain a separate license. Any licensing of Modifications requires additional rights from EVERCYTE. 2.3 Any Commercial Use of the EVERCYTE Material is strictly prohibited without EVERCYTE’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain EVERCYTE Material may require a license from a person or entity not party to this MTA or be subject to restrictions that may be imposed by a person or entity not party to this MTA. 2.4 Upon termination or expiration of this MTA Purchaser shall stop to use Evercyte Material(s) and Purchaser shall confirm in writing by authorized persons the destruction of remaining EVERCYTE Material(s) in Principal Investigator’s laboratory. The Certificate of Destruction is available online (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/certificate-of-destruction) or upon request.

Appears in 3 contracts

Sources: Material Transfer Agreement, Material Transfer Agreement, Material Transfer Agreement

Scope of Use. 2.1 Subject to the terms of this MTA, Principal Investigator may use the EVERCYTE Materials provided to Purchaser by EVERCYTE Biological Material during the License Term for the use of Biological Material for non-exclusive research purposes and development purposes, including EV-testing and production of any kind of cell-derived products (e.g. EV’s, RNA, proteins, etc.), excluding the production of clinical grade material, in one Principal Investigator’s laboratory only. EVERCYTE Biological Material is not intended for use in humans. Purchaser LICENSEE agrees that EVERCYTE Materials Biological Material designated as biosafety greater than 1 constitute known pathogens and that EVERCYTE Materials Biological Material not designated this way may be pathogenic under certain conditions (for further details see PDS). Purchaser LICENSEE assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and PurchaserLICENSEE’s use of the EVERCYTE Materials Biological Material including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser LICENSEE agrees that any activity undertaken with the EVERCYTE Materials Biological Material will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser LICENSEE will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaserLICENSEE’s receipt, handling, storage, disposal, transfer and use of the EVERCYTE MaterialsBiological Material. 2.2 Purchaser LICENSEE shall not distribute, sell, lend or otherwise transfer, to a person other than the Principal Investigator, or entity not party to this MTA, the EVERCYTE Biological Material, as defined above, for any reason, without EVERCYTE’s prior written consent. Purchaser LICENSEE may not transfer the EVERCYTE Biological Material to any third partiesThird Parties. Purchaser LICENSEE agrees that any investigator other than the Principal Investigator utilizing the EVERCYTE Biological Material will be required to obtain a separate license. Any licensing of Modifications requires additional rights from EVERCYTE. 2.3 Any Commercial Use of the EVERCYTE Biological Material is strictly prohibited without EVERCYTE’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain EVERCYTE Material may require a license from a person or entity not party to this MTA or be subject to restrictions that may be imposed by a person or entity not party to this MTA. 2.4 Upon termination or expiration of this MTA Purchaser LICENSEE shall stop to use Evercyte Material(s) the Biological Material and Purchaser LICENSEE shall confirm in writing by authorized persons the destruction of remaining EVERCYTE Biological Material(s) in Principal Investigator’s laboratory. The Certificate of Destruction is available online (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/certificate-of-destruction) or upon request.

Appears in 3 contracts

Sources: Material Transfer Agreement, Material Transfer Agreement, Material Transfer Agreement

Scope of Use. 2.1 Subject to the terms of this MTA, Principal Investigator may use the EVERCYTE Materials provided to Purchaser by EVERCYTE Biological Material during the License Term for the use of Biological Material for non-exclusive research purposes and development purposes, including EV-testing and production of any kind of cell-derived products (e.g. EV’s, RNA, proteins, etc.), excluding the production of material for clinical application or clinical grade material, in one Principal Investigator’s laboratory only. EVERCYTE . 2.2 Biological Material is not intended for use in humans. Purchaser LICENSEE agrees that EVERCYTE Materials Biological Material designated as biosafety greater than 1 constitute known pathogens and that EVERCYTE Materials Biological Material not designated this way may be pathogenic under certain conditions (for further details see PDS)conditions. Purchaser LICENSEE assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and PurchaserLICENSEE’s use of the EVERCYTE Materials Biological Material including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser agrees that any activity undertaken with the EVERCYTE Materials will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaser’s receipt, handling, storage, disposal, transfer and use of the EVERCYTE Materials. 2.2 Purchaser 2.3 LICENSEE shall not distribute, sell, lend or otherwise transfer, to a person other than the Principal Investigator, or entity not party to this MTA, the EVERCYTE Biological Material, as defined above, for any reason, without EVERCYTE’s prior written consent. Purchaser LICENSEE may not transfer the EVERCYTE Biological Material to any third partiesThird Parties. Purchaser LICENSEE agrees that any investigator other than the Principal Investigator utilizing the EVERCYTE Biological Material will be required to obtain a separate license. Any licensing of Modifications requires additional rights from EVERCYTE. 2.3 2.4 Any Commercial Use of the EVERCYTE Biological Material is strictly prohibited without EVERCYTE’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain EVERCYTE Material may require a license from a person or entity not party to this MTA or be subject to restrictions that may be imposed by a person or entity not party to this MTA. 2.4 2.5 Upon termination or expiration of this MTA Purchaser LICENSEE shall stop to use Evercyte Material(s) the Biological Material and Purchaser LICENSEE shall confirm in writing by authorized persons the destruction of remaining EVERCYTE Biological Material(s) in Principal Investigator’s laboratory. The Certificate of Destruction is available online (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/certificate-of-destruction) or upon request.

Appears in 2 contracts

Sources: Material Transfer Agreement, Material Transfer Agreement

Scope of Use. 2.1 2.1. Subject to the terms of this MTA, Principal Investigator investigator may use the EVERCYTE Materials provided to Purchaser by EVERCYTE during the License Term for non-exclusive research purposes in one Principal Investigator’s laboratory only. EVERCYTE Material is not intended for use in humans. Purchaser agrees that EVERCYTE Materials designated as biosafety greater than 1 constitute known pathogens and that EVERCYTE Materials not designated this way may be pathogenic under certain conditions (for further details see PDS). Purchaser assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and Purchaser’s use of the EVERCYTE Materials including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser agrees that any activity undertaken with the EVERCYTE Materials will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaser’s receipt, handling, storage, disposal, transfer and use of the EVERCYTE Materials. 2.2 2.2. Purchaser shall not distribute, sell, lend or otherwise transfer, to a person other than the Principal Investigator, or entity not party to this MTA, the EVERCYTE Material, as defined above, for any reason, without EVERCYTE’s prior written consent. Purchaser may not transfer the EVERCYTE Material to any third parties. Purchaser agrees that any investigator other than the Principal Investigator utilizing the EVERCYTE Material will be required to obtain a separate license. Any licensing of Modifications requires additional rights from EVERCYTE. 2.3 2.3. Any Commercial Use of the EVERCYTE Material is strictly prohibited without EVERCYTE’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain EVERCYTE Material may require a license from a person or entity not party to this MTA or be subject to restrictions that may be imposed by a person or entity not party to this MTA. 2.4 2.4. Upon termination or expiration of this MTA Purchaser shall stop to use Evercyte Material(s) and Purchaser shall confirm in writing by authorized persons the destruction of remaining EVERCYTE Material(s) in Principal Investigator’s laboratory. The Certificate of Destruction is available online (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/certificate-of-destruction) or upon request.

Appears in 1 contract

Sources: Material Transfer Agreement

Scope of Use. 2.1 Subject to the terms of this MTA, Principal Investigator may use the EVERCYTE Materials provided to Purchaser by EVERCYTE Biological Material during the License Term for the use of Biological Material for non-exclusive research purposes and development purposes, including EV-testing and production of any kind of cell-derived products (e.g. EV’s, RNA, proteins, etc.), excluding the production of material for clinical application or clinical grade material, in one Principal Investigator’s laboratory only. EVERCYTE . 2.2 Biological Material is not intended for use in humans. Purchaser LICENSEE agrees that EVERCYTE Materials Biological Material designated as biosafety greater than 1 constitute known pathogens and that EVERCYTE Materials Biological Material not designated this way may be pathogenic under certain conditions (for further details see PDS)conditions. Purchaser LICENSEE assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and PurchaserLICENSEE’s use of the EVERCYTE Materials Biological Material including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser agrees that any activity undertaken with the EVERCYTE Materials will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaser’s receipt, handling, storage, disposal, transfer and use of the EVERCYTE Materials. 2.2 Purchaser 2.3 LICENSEE shall not distribute, sell, lend or otherwise transfer, to a person other than the Principal Investigator, or entity not party to this MTA, the EVERCYTE Biological Material, as defined above, for any reason, without EVERCYTE’s prior written consent. Purchaser LICENSEE may not transfer the EVERCYTE Biological Material to any third partiesThird Parties. Purchaser ▇▇▇▇▇▇▇▇ agrees that any investigator other than the Principal Investigator utilizing the EVERCYTE Biological Material will be required to obtain a separate license. Any licensing of Modifications requires additional rights from EVERCYTE. 2.3 2.4 Any Commercial Use of the EVERCYTE Biological Material is strictly prohibited without EVERCYTE’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain EVERCYTE Material may require a license from a person or entity not party to this MTA or be subject to restrictions that may be imposed by a person or entity not party to this MTA. 2.4 2.5 Upon termination or expiration of this MTA Purchaser LICENSEE shall stop to use Evercyte Material(s) the Biological Material and Purchaser LICENSEE shall confirm in writing by authorized persons the destruction of remaining EVERCYTE Biological Material(s) in Principal Investigator’s laboratory. The Certificate of Destruction is available online (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/certificate-of-destruction) or upon request.

Appears in 1 contract

Sources: Material Transfer Agreement

Scope of Use. 2.1 2.1. Subject to the terms of this MTA, Principal Investigator investigator may use the EVERCYTE Materials provided to Purchaser by EVERCYTE during the License Term for non-exclusive research purposes in one Principal Investigator’s laboratory only. EVERCYTE Material is not intended for use in humans. Purchaser agrees that EVERCYTE Materials designated as biosafety greater than 1 constitute known pathogens and that EVERCYTE Materials not designated this way may be pathogenic under certain conditions (for further details see PDS). Purchaser assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and Purchaser’s use of the EVERCYTE Materials including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser agrees that any activity undertaken with the EVERCYTE Materials will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaser’s receipt, handling, storage, disposal, transfer and use of the EVERCYTE Materials. 2.2 2.2. Purchaser shall not distribute, sell, lend or otherwise transfer, to a person other than the Principal Investigator, or entity not party to this MTA, the EVERCYTE Material, as defined above, for any reason, without EVERCYTE’s prior written consent. Purchaser may not transfer the EVERCYTE Material to any third parties. Purchaser agrees that any investigator other than the Principal Investigator utilizing the EVERCYTE Material will be required to obtain a separate license. Any licensing of Modifications requires additional rights from EVERCYTE. 2.3 2.3. Any Commercial Use of the EVERCYTE Material is strictly prohibited without EVERCYTE’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain EVERCYTE Material may require a license from a person or entity not party to this MTA or be subject to restrictions that may be imposed by a person or entity not party to this MTA. 2.4 2.4. Upon termination or expiration of this MTA Purchaser shall stop to use Evercyte Material(s) Purchaser and Purchaser shall confirm in writing by authorized persons the destruction of remaining EVERCYTE Material(s) in Principal Investigator’s laboratory. The Certificate of Destruction is available online (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/certificate-of-destruction) or upon request.

Appears in 1 contract

Sources: Material Transfer Agreement

Scope of Use. 2.1 2.1. Subject to the terms of this MTA, Principal Investigator may use the EVERCYTE Materials provided to Purchaser by EVERCYTE during the License Term for non-exclusive research purposes in one Principal Investigator’s laboratory only. EVERCYTE Material is not intended for use in humans. Purchaser agrees that EVERCYTE Materials designated as biosafety greater than 1 constitute known pathogens and that EVERCYTE Materials not designated this way may be pathogenic under certain conditions (for further details see PDS). Purchaser assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and Purchaser’s use of the EVERCYTE Materials including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser agrees that any activity undertaken with the EVERCYTE Materials will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaser’s receipt, handling, storage, disposal, transfer and use of the EVERCYTE Materials. 2.2 2.2. Purchaser shall not distribute, sell, lend or otherwise transfer, to a person other than the Principal Investigator, or entity not party to this MTA, the EVERCYTE Material, as defined above, for any reason, without EVERCYTE’s prior written consent. Purchaser may not transfer the EVERCYTE Material to any third parties. Purchaser agrees that any investigator other than the Principal Investigator utilizing the EVERCYTE Material will be required to obtain a separate license. Any licensing of Modifications requires additional rights from EVERCYTE. 2.3 2.3. Any Commercial Use of the EVERCYTE Material is strictly prohibited without EVERCYTE’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain EVERCYTE Material may require a license from a person or entity not party to this MTA or be subject to restrictions that may be imposed by a person or entity not party to this MTA. 2.4 2.4. Upon termination or expiration of this MTA Purchaser shall stop to use Evercyte Material(s) and Purchaser shall confirm in writing by authorized persons the destruction of remaining EVERCYTE Material(s) in Principal Investigator’s laboratory. The Certificate of Destruction is available online (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/certificate-of-destruction) or upon request.

Appears in 1 contract

Sources: Material Transfer Agreement

Scope of Use. 2.1 Subject to the terms of this MTA, Principal Investigator may use the EVERCYTE Materials Biological Material provided to Purchaser by EVERCYTE via SPI during the License Term of this MTA for the use of for non-exclusive research purposes and development purposes, including EV-testing and production of any kind of cell- derived products (e.g. EV’s, RNA, proteins, etc.), excluding the production of material for clinical application or clinical grade material, in one Principal Investigator’s laboratory only. EVERCYTE . 2.2 Biological Material is not intended for use in humans. Purchaser agrees that EVERCYTE Materials Biological Material designated as biosafety greater than 1 constitute known pathogens and that EVERCYTE Materials Biological Material not designated this way may be pathogenic under certain conditions (for further details see PDS)conditions. Purchaser assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and Purchaser’s use of the EVERCYTE Materials Biological Material including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser agrees that any activity undertaken with the EVERCYTE Materials will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaser’s receipt, handling, storage, disposal, transfer and use of the EVERCYTE Materials. 2.2 2.3 Purchaser shall not distribute, sell, lend or otherwise transfer, to a person other than the Principal Investigator, or entity not party to this MTA, the EVERCYTE Biological Material, as defined above, for any reason, without EVERCYTE’s prior written consentconsent (via SPI). Purchaser may not transfer the EVERCYTE Biological Material to any third partiesThird Parties. Purchaser ▇▇▇▇▇▇▇▇▇ agrees that any investigator other than the Principal Investigator utilizing the EVERCYTE Biological Material will be required to obtain a separate license. Any licensing of Modifications requires additional rights from EVERCYTEEVERCYTE via SPI. 2.3 2.4 Any Commercial Use of the EVERCYTE Biological Material is strictly prohibited without EVERCYTE’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain EVERCYTE Material may require a license from a person or entity not party to this MTA or be subject to restrictions that may be imposed by a person or entity not party to this MTA. 2.4 2.5 Upon termination or expiration of this MTA Purchaser shall stop to use Evercyte Material(s) the Biological Material and Purchaser shall confirm in writing by authorized persons the destruction of remaining EVERCYTE Material(s) Biological Material in Principal Investigator’s laboratory. The Certificate of Destruction is available online (▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇/certificate-of-destruction) or upon request.

Appears in 1 contract

Sources: Material Transfer Agreement